##ANALYSISTYPE=GERMLINE_TRIO
##PIPELINE=megSAP 0.1-753-gd2b1864
##SAMPLE=<ID=father,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=mother,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=child,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##DESCRIPTION=father=genotype of sample father
##DESCRIPTION=mother=genotype of sample mother
##DESCRIPTION=child=genotype of sample child
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - SNP quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM).
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon number, HGVS.c, HGVS.p).
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in all populations of 1000g project.
##DESCRIPTION=ExAC=Allele frequency in all populations of ExAC project.
##DESCRIPTION=ExAC_hom=Homoyzgous counts for populations ALL, NFE and AFR of ExAC project.
##DESCRIPTION=ExAC_sub=Sub-population allele frequenciens for populations AFR,AMR,EAS,NFE,SAS of ExAC project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD database.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=MetaLR=MetaLR effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen2=PolyPhen2 (HVAR) effect prediction: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=FATHMM=FATHMM effect prediction: D=damaging, T=tolerated.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 15-20.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=ihdb_allsys_hom=Homozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=ihdb_allsys_het=Heterozygous variant counts in NGSD independent of the processing system.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validated=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=off-target=Variant marked as 'off-target'.
#chr	start	end	ref	obs	father	mother	child	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_hom	ExAC_sub	gnomAD	phyloP	Sift	MetaLR	PolyPhen2	fathmm-MKL	CADD	OMIM	ClinVar	HGMD	COSMIC	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment	gene_info
chr6	7565730	7565730	G	A	wt	het	wt		QUAL=3340;DP=397,270,213;AF=0.00,0.54,0.00;MQM=60	DSP	missense	DSP:ENST00000379802:missense:MODERATE:exon7/24:c.916G>A:p.Ala306Thr,DSP:ENST00000418664:missense:MODERATE:exon7/24:c.916G>A:p.Ala306Thr		rs368193211	0	0.0001	0,0,0	0.0000,0.0000,0.0004,0.0001,0.0000	0.0001	2.6700	T,T,T	T	B,B	D,D	21.90	125647 [DSP (confirmed) Keratosis palmoplantaris striata II,612908|Cardiomyopathy,dilated,with woolly hair and keratoderma,605676|Arrhythmogenic right ventricular dysplasia 8,607450|Skin fragility-woolly hair syndrome,607655|Epidermolysis bullosa,lethal acantholytic,609638|Dilated cardiomyopathy with woolly hair,keratoderma,and tooth agenesis,615821];	44981 [uncertain significance DISEASE=arrhythmogenic_right_ventricular_cardiomyopathy,_type_8,cardiomyopathy_dilated_with_woolly_hair_and_keratoderma,not_specified]; 	CM1413441 [CLASS=DM? MUT=ALT PHEN="Sudden cardiac death" GENE=DSP]; 		0	2	3	[3] faust 10.05.2018			DSP (inh=AR+AD pLI=1.00)
chr6	18122873	18122873	C	G	wt	het	wt	off-target	QUAL=558;DP=52,47,10;AF=0.00,0.53,0.00;MQM=60	NHLRC1,TPMT	intergenic_region	TPMT:ENSG00000187566-ENSG00000137364:intergenic_region:MODIFIER::n.18122873C>G:		rs763144619	0	0.0002	0,0,0	0.0000,0.0000,0.0000,0.0002,0.0000	0.0006								206176 [benign DISEASE=not_specified]; 			0	3					NHLRC1 (inh=AR pLI=0.03), TPMT (inh=AR pLI=0.00)
chr6	24535179	24535179	T	G	wt	het	het		QUAL=8454;DP=272,234,388;AF=0.00,0.58,0.48;MQM=60	ALDH5A1	3'UTR	ALDH5A1:ENST00000357578:3'UTR:MODIFIER:exon10/10:c.*1239T>G:		rs191960134	0.0026	0	0,0,0	0,0,0,0,0	0.0074							610045 [ALDH5A1 (confirmed) Succinic semialdehyde dehydrogenase deficiency,271980];	356162 [uncertain significance DISEASE=succinate-semialdehyde_dehydrogenase_deficiency]; 			0	4					ALDH5A1 (inh=AR pLI=0.00)
chr6	24535817	24535817	A	G	wt	het	het		QUAL=3162;DP=140,117,219;AF=0.01,0.37,0.41;MQM=56	ALDH5A1	3'UTR	ALDH5A1:ENST00000357578:3'UTR:MODIFIER:exon10/10:c.*1877A>G:	AluY	rs41271787	0.0026	0	0,0,0	0,0,0,0,0	0.0073							610045 [ALDH5A1 (confirmed) Succinic semialdehyde dehydrogenase deficiency,271980];				0	3					ALDH5A1 (inh=AR pLI=0.00)
chr6	31829172	31829172	C	T	wt	het	wt		QUAL=1043;DP=97,87,164;AF=0.01,0.52,0.00;MQM=60	NEU1	synonymous	NEU1:ENST00000375631:synonymous:LOW:exon3/6:c.408G>A:p.Gly136Gly		rs41267074	0.0006	0.0011	0,0,0	0.0003,0.0001,0.0000,0.0020,0.0000	0.0011							608272 [NEU1 (confirmed) Sialidosis,type I,256550|Sialidosis,type II,256550];				0	15	2	[2] ahdeinn1 12.06.2017			NEU1 (inh=AR pLI=0.00)
chr6	32796451	32796451	A	C	het	wt	het		QUAL=1546;DP=79,45,97;AF=0.44,0.00,0.36;MQM=59	TAP2	3'UTR,intron	TAP2:ENST00000374897:3'UTR:MODIFIER:exon12/12:c.*232T>G:,TAP2:ENST00000452392:intron:MODIFIER:exon11/14:c.1932+726T>G:,TAP2:ENST00000374899:intron:MODIFIER:exon11/11:c.1932+726T>G:		rs141809764	0.0038	0	0,0,0	0,0,0,0,0	0.0054							170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency,604571|Wegener-like granulomatosis];				0	5					TAP2 (inh=AR pLI=0.00)
chr6	32806530	32806530	C	G	het	wt	het		QUAL=2096;DP=85,47,64;AF=0.56,0.00,0.66;MQM=60	TAP2	5'UTR	TAP2:ENST00000452392:5'UTR:MODIFIER:exon1/15:c.-105G>C:,TAP2:ENST00000374897:5'UTR:MODIFIER:exon1/12:c.-105G>C:		rs146973617	0.0032	0	0,0,0	0,0,0,0,0	0.005							170261 [TAP2 (confirmed) Bare lymphocyte syndrome,type I,due to TAP2 deficiency,604571|Wegener-like granulomatosis];				0	7					TAP2 (inh=AR pLI=0.00)
chr6	32814909	32814909	C	T	het	wt	het		QUAL=4762;DP=189,172,267;AF=0.40,0.00,0.45;MQM=60	TAP1,PSMB9	missense,intron	TAP1:ENST00000354258:missense:MODERATE:exon10/11:c.2156G>A:p.Arg719Gln,TAP1:ENST00000425148:missense:MODERATE:exon10/11:c.1373G>A:p.Arg458Gln,PSMB9:ENST00000395330:intron:MODIFIER:exon1/5:c.-10+2858C>T:		rs121917702	0.0008	0.0016	1,1,0	0.0001,0.0000,0.0000,0.0027,0.0002	0.0012	3.0610	D,D	D	P	D,D	34.00	170260 [TAP1 (confirmed) Bare lymphocyte syndrome,type I,604571];	13731 [conflicting interpretations of pathogenicity DISEASE=bare_lymphocyte_syndrome_type_1,tap1_deficiency,_somatic]; 	CM963078 [CLASS=DM MUT=ALT PHEN="HLA class I deficiency" GENE=TAP1]; 		0	14					TAP1 (inh=AR pLI=0.29), PSMB9 (inh=n/a pLI=0.23)
chr6	33269367	33269367	G	A	wt	wt	hom		QUAL=180;DP=14,17,59;AF=0.21,0.47,0.47;MQM=51	TAPBP	3'UTR	TAPBP:ENST00000434618:3'UTR:MODIFIER:exon8/8:c.*170C>T:	AluSx	rs376854995	0	0	0,0,0	0,0,0,0,0	0.0029							601962 [TAPBP (provisional) Bare lymphocyte syndrome,type I,604571];				0	6					TAPBP (inh=AR pLI=0.01)
chr6	49399315	49399315	T	C	wt	het	het		QUAL=3443;DP=104,86,213;AF=0.00,0.40,0.46;MQM=60	MUT	3'UTR	MUT:ENST00000274813:3'UTR:MODIFIER:exon13/13:c.*126A>G:		rs192605776	0.0014	0	0,0,0	0,0,0,0,0	0.0027							609058 [MUT (confirmed) Methylmalonic aciduria,mut(0) type,251000];	357250 [uncertain significance DISEASE=methylmalonic_acidemia]; 			0	4					MUT (inh=AR pLI=0.00)
chr6	88224047	88224047	A	T	wt	het	het	off-target	QUAL=1457;DP=62,42,128;AF=0.00,0.38,0.45;MQM=54	SLC35A1,RARS2	intergenic_region	RARS2:ENSG00000164414-ENSG00000146282:intergenic_region:MODIFIER::n.88224047A>T:	AluSp	rs1056869703	0	0	0,0,0	0,0,0,0,0	0.0001											0	2					SLC35A1 (inh=AR pLI=0.21), RARS2 (inh=AR pLI=0.00)
chr6	88272388	88272388	A	C	wt	het	het	off-target	QUAL=3981;DP=170,117,170;AF=0.00,0.46,0.58;MQM=60	RARS2	intron	RARS2:ENST00000369536:intron:MODIFIER:exon4/19:c.297+32T>G:	L2b		0	0	0,0,0	0,0,0,0,0	0							611524 [RARS2 (confirmed) Pontocerebellar hypoplasia,type 6,611523];				0	2					RARS2 (inh=AR pLI=0.00)
chr6	110933257	110933257	G	A	wt	het	wt		QUAL=3486;DP=430,330,594;AF=0.00,0.43,0.00;MQM=60	CDK19	3'UTR	CDK19:ENST00000368911:3'UTR:MODIFIER:exon13/13:c.*2481C>T:,CDK19:ENST00000323817:3'UTR:MODIFIER:exon14/14:c.*2481C>T:			0	0	0,0,0	0,0,0,0,0	0											0	1					CDK19 (inh=n/a pLI=1.00)
chr6	116597644	116597644	G	C	het	wt	wt		QUAL=2476;DP=156,174,506;AF=0.60,0.00,0.00;MQM=60	DSE	intron	DSE:ENST00000540275:intron:MODIFIER:exon2/3:c.524+17514G>C:		rs183668323	0.0016	0	0,0,0	0,0,0,0,0	0.0067							605942 [DSE (provisional) Ehlers-Danlos syndrome,musculocontractural type 2,615539]:604714 [TSPYL1 (confirmed) Sudden infant death with dysgenesis of the testes syndrome,608800];				0	2					DSE (inh=AR pLI=0.25)
chr6	132212889	132212890	TT	-	wt	wt	hom		QUAL=62;DP=20,12,46;AF=0.25,0.08,0.28;MQM=60	ENPP1	3'UTR	ENPP1:ENST00000360971:3'UTR:MODIFIER:exon25/25:c.*1255_*1256delTT:		rs769107294	0	0	0,0,0	0,0,0,0,0	0							173335 [ENPP1 (confirmed) Diabetes mellitus,non-insulin-dependent,susceptibility to,125853|Obesity,susceptibility to,601665|Arterial calcification,generalized,of infancy,1,208000|Hypophosphatemic rickets,autosomal recessive,2,613312|Cole disease,615522];				1	0					ENPP1 (inh=AR+AD pLI=0.00)
chr6	152774753	152774753	C	T	wt	het	het		QUAL=4880;DP=141,123,243;AF=0.00,0.59,0.50;MQM=59	SYNE1	missense	SYNE1:ENST00000265368:missense:MODERATE:exon25/146:c.2995G>A:p.Glu999Lys,SYNE1:ENST00000367255:missense:MODERATE:exon25/146:c.2995G>A:p.Glu999Lys,SYNE1:ENST00000423061:missense:MODERATE:exon25/146:c.3016G>A:p.Glu1006Lys,SYNE1:ENST00000341594:missense:MODERATE:exon28/147:c.3193G>A:p.Glu1065Lys,SYNE1:ENST00000448038:missense:MODERATE:exon26/147:c.3016G>A:p.Glu1006Lys,SYNE1:ENST00000367253:missense:MODERATE:exon23/36:c.2995G>A:p.Glu999Lys,SYNE1:ENST00000367248:missense:MODERATE:exon24/32:c.2965G>A:p.Glu989Lys,SYNE1:ENST00000413186:missense:MODERATE:exon23/31:c.2995G>A:p.Glu999Lys,SYNE1:ENST00000495090:missense:MODERATE:exon12/12:c.1696G>A:p.Glu566Lys		rs148346599	0.002	0.0034	2,0,0	0.0001,0.0001,0.0000,0.0032,0.0032	0.0038	7.3880	D,D,D,D,D,D,T,D,T	T	P,P,P,D,D,P,D	T,T,T,T,T,T,T,T,T	27.30	608441 [SYNE1 (confirmed) Spinocerebellar ataxia,autosomal recessive 8,610743|Emery-Dreifuss muscular dystrophy 4,autosomal dominant,612998];	281136 [benign/likely benign DISEASE=cerebellar_ataxia,emery-dreifuss_muscular_dystrophy,not_specified]; 		COSM231095, COSM231094	0	20					SYNE1 (inh=AR+AD pLI=0.00)
chr6	162683814	162683814	T	A	hom	hom	hom	off-target	QUAL=3049;DP=65,45,22;AF=0.03,0.04,0.14;MQM=58	PARK2	splice_region&intron,intron	PARK2:ENST00000366898:splice_region&intron:LOW:exon2/11:c.172-17A>T:,PARK2:ENST00000366897:splice_region&intron:LOW:exon2/10:c.172-17A>T:,PARK2:ENST00000338468:splice_region&intron:LOW:exon2/10:c.-280-17A>T:,PARK2:ENST00000366892:splice_region&intron:LOW:exon2/9:c.172-17A>T:,PARK2:ENST00000366896:intron:MODIFIER:exon2/8:c.171+180528A>T:,PARK2:ENST00000366894:intron:MODIFIER:exon2/10:c.-161-61530A>T:			0	0	0,0,0	0,0,0,0,0	0.0084							602544 [PARK2 (confirmed) Parkinson disease,juvenile,type 2,600116|Adenocarcinoma of lung,somatic,211980|Adenocarcinoma,ovarian,somatic,167000|Leprosy,susceptibility to,607572];				0	1					PRKN (inh=AR+AD pLI=0.01)
chr12	7048292	7048292	C	T	wt	wt	het		QUAL=2189;DP=420,302,209;AF=0.00,0.00,0.46;MQM=60	ATN1	missense	ATN1:ENST00000356654:missense:MODERATE:exon7/10:c.3166C>T:p.His1056Tyr,ATN1:ENST00000396684:missense:MODERATE:exon7/10:c.3166C>T:p.His1056Tyr	(CACCAG)n		0	0	0,0,0	0,0,0,0,0	0	7.6510	D,D,D,D	D	P	D,D,D	28.60	607462 [ATN1 (confirmed) Dentatorubro-pallidoluysian atrophy,125370];				0	1					ATN1 (inh=AD pLI=1.00)
chr12	8755737	8755737	C	T	hom	hom	hom		QUAL=2663;DP=27,15,22;AF=0.15,0.07,0.00;MQM=60	AICDA	3'UTR	AICDA:ENST00000229335:3'UTR:MODIFIER:exon5/5:c.*1143G>A:	(TTCTCT)n	rs1039558189	0	0	0,0,0	0,0,0,0,0	0.0006							605257 [AICDA (confirmed) Immunodeficiency with hyper-IgM,type 2,605258];				0	0					AICDA (inh=AR pLI=0.03)
chr12	31226795	31226795	T	G	het	het	wt		QUAL=41;DP=47,38,32;AF=0.47,0.32,0.13;MQM=58	DDX11	5'UTR	DDX11:ENST00000407793:5'UTR:MODIFIER:exon1/27:c.-235T>G:,DDX11:ENST00000542838:5'UTR:MODIFIER:exon1/27:c.-235T>G:,DDX11:ENST00000251758:5'UTR:MODIFIER:exon1/28:c.-235T>G:,DDX11:ENST00000228264:5'UTR:MODIFIER:exon1/27:c.-118T>G:		rs1029809307	0	0	0,0,0	0,0,0,0,0	0							601150 [DDX11 (provisional) Warsaw breakage syndrome,613398];				0	2					DDX11 (inh=AR pLI=0.00)
chr12	56087806	56087806	G	A	wt	het	wt		QUAL=4667;DP=388,363,222;AF=0.00,0.51,0.00;MQM=60	ITGA7	missense&splice_region	ITGA7:ENST00000555728:missense&splice_region:MODERATE:exon20/26:c.2666C>T:p.Thr889Met,ITGA7:ENST00000553804:missense&splice_region:MODERATE:exon19/25:c.2546C>T:p.Thr849Met,ITGA7:ENST00000257879:missense&splice_region:MODERATE:exon19/25:c.2534C>T:p.Thr845Met,ITGA7:ENST00000347027:missense&splice_region:MODERATE:exon19/25:c.2516C>T:p.Thr839Met,ITGA7:ENST00000452168:missense&splice_region:MODERATE:exon19/25:c.2255C>T:p.Thr752Met,ITGA7:ENST00000257880:missense&splice_region:MODERATE:exon20/27:c.2666C>T:p.Thr889Met,ITGA7:ENST00000394229:missense&splice_region:MODERATE:exon19/26:c.2534C>T:p.Thr845Met,ITGA7:ENST00000394230:missense&splice_region:MODERATE:exon19/26:c.2546C>T:p.Thr849Met		rs55654066	0	0.0001	0,0,0	0.0001,0.0000,0.0000,0.0000,0.0000	0.0001	1.3890	D,D,D,D,D,D,D,T,D	T	P,P,B,P	T,T,T,T,T,T,T,T	26.30	600536 [ITGA7 (provisional) Muscular dystrophy,congenital,due to ITGA7 deficiency,613204];				0	3					ITGA7 (inh=AR pLI=0.00)
chr12	65108586	65108586	G	C	het	wt	het		QUAL=5333;DP=166,116,251;AF=0.50,0.00,0.46;MQM=60	GNS	3'UTR	GNS:ENST00000418919:3'UTR:MODIFIER:exon13/13:c.*1935C>G:,GNS:ENST00000258145:3'UTR:MODIFIER:exon14/14:c.*1935C>G:		rs899920283	0	0	0,0,0	0,0,0,0,0	0.0002							607664 [GNS (provisional) Mucopolysaccharidosis type IIID,252940];				0	2					GNS (inh=AR pLI=0.57)
chr12	66218507	66218507	-	TCTCTG	hom	hom	hom		QUAL=4629;DP=99,41,39;AF=0.00,0.20,0.00;MQM=60	HMGA2,RPSAP52	5'UTR,intron	HMGA2:ENST00000536545:5'UTR:MODIFIER:exon1/4:c.-539_-538insGTCTCT:,HMGA2:ENST00000403681:5'UTR:MODIFIER:exon1/5:c.-539_-538insGTCTCT:,HMGA2:ENST00000393578:5'UTR:MODIFIER:exon1/4:c.-539_-538insGTCTCT:,HMGA2:ENST00000425208:5'UTR:MODIFIER:exon1/4:c.-539_-538insGTCTCT:,HMGA2:ENST00000354636:5'UTR:MODIFIER:exon1/4:c.-539_-538insGTCTCT:,RPSAP52:ENST00000489520:intron:MODIFIER:exon1/1:n.132+2115_132+2116insCAGAGA:	(TC)n		0	0	0,0,0	0,0,0,0,0	0.009							600698 [HMGA2 (confirmed) Leiomyoma,uterine,somatic,150699];				0	0					HMGA2 (inh=AD pLI=0.72), RPSAP52 (inh=n/a pLI=n/a)
chr12	109540752	109540752	A	TT	wt	wt	hom	off-target	QUAL=314;DP=20,17,19;AF=0.00,0.12,0.37;MQM=51	UNG	splice_region&intron	UNG:ENST00000242576:splice_region&intron:LOW:exon5/6:c.622+20delAinsTT:,UNG:ENST00000336865:splice_region&intron:LOW:exon4/5:c.595+20delAinsTT:			0	0	0,0,0	0,0,0,0,0	0							191525 [UNG (confirmed) Immunodeficiency with hyper IgM,type 5,608106];				1	2					UNG (inh=AR pLI=0.16)
chr12	109993255	109993259	TTTTT	-	hom	hom	hom		QUAL=1586;DP=55,39,20;AF=0.04,0.18,0.00;MQM=56	MMAB	3'UTR	MMAB:ENST00000545712:3'UTR:MODIFIER:exon9/9:c.*1574_*1578delAAAAA:	AluSx1	rs768035056	0	0.0078	0,0,0	0.0000,0.0000,0.0000,0.0000,0.0090	0.0056							607568 [MMAB (provisional) Methylmalonic aciduria,vitamin B12-responsive,due to defect in synthesis of adenosylcobalamin,cblB complementation type,251110];				7	0					MMAB (inh=AR pLI=0.02)
chr12	110240908	110240908	C	T	wt	het	wt		QUAL=2247;DP=315,198,334;AF=0.00,0.48,0.00;MQM=60	TRPV4	synonymous	TRPV4:ENST00000261740:synonymous:LOW:exon4/16:c.600G>A:p.Leu200Leu,TRPV4:ENST00000418703:synonymous:LOW:exon3/15:c.600G>A:p.Leu200Leu,TRPV4:ENST00000346520:synonymous:LOW:exon4/15:c.600G>A:p.Leu200Leu,TRPV4:ENST00000392719:synonymous:LOW:exon4/15:c.600G>A:p.Leu200Leu,TRPV4:ENST00000536838:synonymous:LOW:exon4/16:c.498G>A:p.Leu166Leu,TRPV4:ENST00000537083:synonymous:LOW:exon3/14:c.600G>A:p.Leu200Leu,TRPV4:ENST00000541794:synonymous:LOW:exon3/14:c.600G>A:p.Leu200Leu,TRPV4:ENST00000544971:synonymous:LOW:exon3/13:c.600G>A:p.Leu200Leu			0	0	0,0,0	0,0,0,0,0	0							605427 [TRPV4 (confirmed) Brachyolmia type 3,113500|Spondylometaphyseal dysplasia,Kozlowski type,184252|Metatropic dysplasia,156530|Hereditary motor and sensory neuropathy,type IIc,606071|Scapuloperoneal spinal muscular atrophy,181405|Sodium serum level QTL 1,613508|Parastremmatic dwarfism,168400|SED,Maroteaux type,184095|Spinal muscular atrophy,distal,congenital nonprogressive,600175|Digital arthropathy-brachydactyly,familial,606835|Avascular necrosis of femoral head,primary,2,617383];				0	1					TRPV4 (inh=AD pLI=0.00)
chr12	121440039	121440039	G	A	het	wt	wt		QUAL=695;DP=68,70,95;AF=0.47,0.01,0.01;MQM=60	HNF1A	3'UTR	HNF1A:ENST00000541395:3'UTR:MODIFIER:exon9/9:c.*1044G>A:,HNF1A:ENST00000257555:3'UTR:MODIFIER:exon10/10:c.*1044G>A:		rs1039799815	0	0	0,0,0	0,0,0,0,0	0.0007							142410 [HNF1A (confirmed) MODY,type III,600496|Diabetes mellitus,noninsulin-dependent,2,125853|Diabetes mellitus,insulin-dependent,222100|Hepatic adenoma,somatic,142330|Renal cell carcinoma,144700|Diabetes mellitus,insulin-dependent,20,612520];				0	1					HNF1A (inh=AD pLI=0.99)
chr12	122756470	122756470	C	A	het	wt	het		QUAL=4285;DP=143,93,229;AF=0.48,0.00,0.42;MQM=60	CLIP1	3'UTR	CLIP1:ENST00000361654:3'UTR:MODIFIER:exon24/24:c.*952G>T:,CLIP1:ENST00000545889:3'UTR:MODIFIER:exon21/21:c.*952G>T:,CLIP1:ENST00000302528:3'UTR:MODIFIER:exon24/24:c.*952G>T:,CLIP1:ENST00000358808:3'UTR:MODIFIER:exon25/25:c.*952G>T:		rs112052364	0.0012	0	0,0,0	0,0,0,0,0	0.0014											0	7					CLIP1 (inh=n/a pLI=0.89)
chr12	122962338	122962340	AAA	-	hom	hom	hom	off-target	QUAL=719;DP=36,35,67;AF=0.03,0.11,0.06;MQM=56	ZCCHC8	intron	ZCCHC8:ENST00000336229:intron:MODIFIER:exon13/13:c.1345+48_1345+50delTTT:,ZCCHC8:ENST00000536306:intron:MODIFIER:exon11/11:c.631+48_631+50delTTT:,ZCCHC8:ENST00000543897:intron:MODIFIER:exon11/11:c.631+48_631+50delTTT:,ZCCHC8:ENST00000538116:intron:MODIFIER:exon2/2:c.178+48_178+50delTTT:	AluSg		0	0	0,0,0	0,0,0,0,0	0.0079											0	0					ZCCHC8 (inh=n/a pLI=0.65)
chr17	3564510	3564510	C	T	wt	het	wt		QUAL=3505;DP=456,339,186;AF=0.00,0.43,0.00;MQM=60	CTNS	3'UTR	CTNS:ENST00000381870:3'UTR:MODIFIER:exon13/13:c.*482C>T:,CTNS:ENST00000046640:3'UTR:MODIFIER:exon12/12:c.*847C>T:		rs146131305	0.0046	0	0,0,0	0,0,0,0,0	0.0092							606272 [CTNS (confirmed) Cystinosis,nephropathic,219800|Cystinosis,ocular nonnephropathic,219750|Cystinosis,late-onset juvenile or adolescent nephropathic,219900|Cystinosis,atypical nephropathic,219800];	322866 [uncertain significance DISEASE=nephropathic_cystinosis,cystinosis]; 			0	5					CTNS (inh=AR pLI=0.02)
chr17	7749879	7749879	C	A	het	wt	het	off-target	QUAL=457;DP=34,27,14;AF=0.41,0.00,0.50;MQM=59	KDM6B	splice_region&intron	KDM6B:ENST00000254846:splice_region&intron:LOW:exon7/21:c.550-18C>A:,KDM6B:ENST00000448097:splice_region&intron:LOW:exon7/22:c.550-18C>A:			0	0	0,0,0	0,0,0,0,0	0											0	2					KDM6B (inh=AR pLI=1.00)
chr17	10555833	10555833	C	T	wt	het	wt		QUAL=840;DP=82,62,43;AF=0.00,0.58,0.02;MQM=60	MYH3	synonymous	MYH3:ENST00000226209:synonymous:LOW:exon3/40:c.252G>A:p.Lys84Lys,MYH3:ENST00000583535:synonymous:LOW:exon4/41:c.252G>A:p.Lys84Lys		rs147410236	0.0002	0.0013	2,2,0	0.0000,0.0001,0.0000,0.0023,0.0000	0.003							160720 [MYH3 (confirmed) Arthrogryposis,distal,type 2A,193700|Arthrogryposis,distal,type 2B,601680|Arthrogryposis,distal,type 8,178110];	321772 [uncertain significance DISEASE=freeman-sheldon_syndrome,arthrogryposis_multiplex_congenita]; 		COSM705051	0	15	2	Prima vista kein Anhalt f?r Splice Defekt, swal, 160309 [2] ahwalds1 09.03.2016			MYH3 (inh=AR+AD pLI=0.00)
chr17	33904933	33904933	A	-	wt	het	wt		QUAL=2976;DP=317,210,336;AF=0.00,0.56,0.00;MQM=60	PEX12	frameshift	PEX12:ENST00000225873:frameshift:HIGH:exon1/3:c.108delT:p.Leu37fs			0	0	0,0,0	0,0,0,0,0	0							601758 [PEX12 (provisional) Peroxisome biogenesis disorder 3A (Zellweger),614859|Peroxisome biogenesis disorder 3B,266510];				0	1					PEX12 (inh=AR pLI=0.00)
chr17	42984085	42984085	C	T	het	wt	het		QUAL=7606;DP=325,252,316;AF=0.50,0.00,0.50;MQM=59	GFAP	3'UTR	GFAP:ENST00000253408:3'UTR:MODIFIER:exon9/9:c.*630G>A:	FLAM_A	rs72828813	0.0036	0	0,0,0	0,0,0,0,0	0.0072							137780 [GFAP (confirmed) Alexander disease,203450];	323603 [likely benign DISEASE=alexander's_disease]; 			0	5					GFAP (inh=AD pLI=0.00)
chr17	42986981	42986981	-	CTC	wt	het	het	off-target	QUAL=124;DP=60,41,76;AF=0.10,0.20,0.21;MQM=60	GFAP	intron	GFAP:ENST00000253408:intron:MODIFIER:exon7/8:c.1171+1001_1171+1002insGAG:,GFAP:ENST00000588735:intron:MODIFIER:exon1/2:c.83-1498_83-1497insGAG:	Charlie30b	rs753468825	0	0	0,0,0	0,0,0,0,0	0.0018							137780 [GFAP (confirmed) Alexander disease,203450];				0	12					GFAP (inh=AD pLI=0.00)
chr17	42986985	42986985	C	G	wt	het	het	off-target	QUAL=113;DP=41,30,46;AF=0.10,0.23,0.30;MQM=60	GFAP	intron	GFAP:ENST00000253408:intron:MODIFIER:exon7/8:c.1171+998G>C:,GFAP:ENST00000588735:intron:MODIFIER:exon1/2:c.83-1501G>C:	Charlie30b	rs796254075	0	0	0,0,0	0,0,0,0,0	0							137780 [GFAP (confirmed) Alexander disease,203450];				6	12					GFAP (inh=AD pLI=0.00)
chr17	42987000	42987000	G	C	het	het	het	off-target	QUAL=84;DP=48,35,29;AF=0.33,0.34,0.17;MQM=58	GFAP	intron	GFAP:ENST00000253408:intron:MODIFIER:exon7/8:c.1171+983C>G:,GFAP:ENST00000588735:intron:MODIFIER:exon1/2:c.83-1516C>G:	Charlie30b		0	0	0,0,0	0,0,0,0,0	0.0095							137780 [GFAP (confirmed) Alexander disease,203450];				0	9					GFAP (inh=AD pLI=0.00)
chr17	48262163	48262163	C	T	het	wt	wt		QUAL=2849;DP=201,153,69;AF=0.60,0.00,0.00;MQM=60	COL1A1	3'UTR	COL1A1:ENST00000225964:3'UTR:MODIFIER:exon51/51:c.*700G>A:			0	0	0,0,0	0,0,0,0,0	0.0001							120150 [COL1A1 (confirmed) Osteogenesis imperfecta,type I,166200|Osteogenesis imperfecta,type II,166210|Osteogenesis imperfecta,type III,259420|Caffey disease,114000|Osteogenesis imperfecta,type IV,166220|Bone mineral density variation QTL,osteoporosis,166710|Ehlers-Danlos syndrome,arthrochalasia type,1,130060];				0	1					COL1A1 (inh=AR+AD pLI=1.00)
chr17	48655672	48655672	G	A	wt	het	wt		QUAL=3601;DP=401,302,215;AF=0.00,0.50,0.00;MQM=60	CACNA1G	missense	CACNA1G:ENST00000359106:missense:MODERATE:exon9/38:c.2048G>A:p.Arg683His,CACNA1G:ENST00000360761:missense:MODERATE:exon9/35:c.2048G>A:p.Arg683His,CACNA1G:ENST00000354983:missense:MODERATE:exon9/36:c.2048G>A:p.Arg683His,CACNA1G:ENST00000352832:missense:MODERATE:exon9/34:c.2048G>A:p.Arg683His,CACNA1G:ENST00000442258:missense:MODERATE:exon9/34:c.2048G>A:p.Arg683His,CACNA1G:ENST00000416767:missense:MODERATE:exon9/23:c.2048G>A:p.Arg683His,CACNA1G:ENST00000502264:missense:MODERATE:exon9/36:c.2048G>A:p.Arg683His,CACNA1G:ENST00000503485:missense:MODERATE:exon9/36:c.2048G>A:p.Arg683His,CACNA1G:ENST00000505165:missense:MODERATE:exon9/37:c.2048G>A:p.Arg683His,CACNA1G:ENST00000507336:missense:MODERATE:exon9/37:c.2048G>A:p.Arg683His,CACNA1G:ENST00000507510:missense:MODERATE:exon9/37:c.2048G>A:p.Arg683His,CACNA1G:ENST00000507609:missense:MODERATE:exon9/36:c.2048G>A:p.Arg683His,CACNA1G:ENST00000507896:missense:MODERATE:exon9/36:c.2048G>A:p.Arg683His,CACNA1G:ENST00000510115:missense:MODERATE:exon9/35:c.2048G>A:p.Arg683His,CACNA1G:ENST00000510366:missense:MODERATE:exon9/35:c.2048G>A:p.Arg683His,CACNA1G:ENST00000512389:missense:MODERATE:exon9/35:c.2048G>A:p.Arg683His,CACNA1G:ENST00000513689:missense:MODERATE:exon9/36:c.2048G>A:p.Arg683His,CACNA1G:ENST00000513964:missense:MODERATE:exon9/35:c.2048G>A:p.Arg683His,CACNA1G:ENST00000514079:missense:MODERATE:exon9/36:c.2048G>A:p.Arg683His,CACNA1G:ENST00000514181:missense:MODERATE:exon9/35:c.2048G>A:p.Arg683His,CACNA1G:ENST00000514717:missense:MODERATE:exon9/35:c.2048G>A:p.Arg683His,CACNA1G:ENST00000515165:missense:MODERATE:exon9/36:c.2048G>A:p.Arg683His,CACNA1G:ENST00000515411:missense:MODERATE:exon9/36:c.2048G>A:p.Arg683His,CACNA1G:ENST00000515765:missense:MODERATE:exon9/36:c.2048G>A:p.Arg683His,CACNA1G:ENST00000429973:missense:MODERATE:exon9/35:c.2048G>A:p.Arg683His,CACNA1G:ENST00000358244:missense:MODERATE:exon9/35:c.2048G>A:p.Arg683His		rs539364383	0.0002	0.0001	0,0,0	0.0002,0.0001,0.0000,0.0001,0.0000	0.0002	0.3920	T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T,T	D	B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B,B	D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D,D	0.11	604065 [CACNA1G (provisional) Spinocerebellar ataxia 42,616795];				0	1					CACNA1G (inh=AD pLI=1.00)
chr17	62006129	62006129	-	G	het	wt	het		QUAL=934;DP=37,34,59;AF=0.54,0.00,0.49;MQM=60	CD79B	3'UTR	CD79B:ENST00000392795:3'UTR:MODIFIER:exon6/6:c.*456dupC:,CD79B:ENST00000006750:3'UTR:MODIFIER:exon6/6:c.*456dupC:		rs554643850	0.0014	0	0,0,0	0,0,0,0,0	0.0051							147245 [CD79B (provisional) Agammaglobulinemia 6,612692];				0	3					CD79B (inh=AR pLI=0.94)
chr17	62006406	62006406	A	G	wt	het	het		QUAL=1802;DP=127,64,96;AF=0.00,0.45,0.48;MQM=60	CD79B,DVL1	3'UTR	CD79B:ENST00000392795:3'UTR:MODIFIER:exon6/6:c.*180T>C:,CD79B:ENST00000006750:3'UTR:MODIFIER:exon6/6:c.*180T>C:		rs147717759	0.003	0	0,0,0	0,0,0,0,0	0.006							147245 [CD79B (provisional) Agammaglobulinemia 6,612692];				0	7					CD79B (inh=AR pLI=0.94)
chr17	62018002	62018002	C	A	het	wt	het		QUAL=5343;DP=241,211,190;AF=0.49,0.00,0.53;MQM=60	SCN4A,LRRTM1	3'UTR	SCN4A:ENST00000435607:3'UTR:MODIFIER:exon24/24:c.*129G>T:,SCN4A:ENST00000578147:3'UTR:MODIFIER:exon24/24:c.*129G>T:		rs140026321	0.0016	0	0,0,0	0,0,0,0,0	0.0051							603967 [SCN4A (confirmed) Hyperkalemic periodic paralysis,type 2,170500|Paramyotonia congenita,168300|Myotonia congenita,atypical,acetazolamide-responsive,608390|Myasthenic syndrome,congenital,16,614198|Hypokalemic periodic paralysis,type 2,613345];	324501 [likely benign DISEASE=hypokalemic_periodic_paralysis,potassium_aggravated_myotonia,paramyotonia_congenita_of_von_eulenburg,congenital_myasthenic_syndrome,_recessive,hyperkalemic_periodic_paralysis]; 			0	3					SCN4A (inh=AR+AD pLI=0.00)
chr17	73728226	73728226	T	C	wt	het	het	off-target	QUAL=3796;DP=269,190,126;AF=0.00,0.48,0.51;MQM=60	ITGB4	splice_region&intron	ITGB4:ENST00000200181:splice_region&intron:LOW:exon11/39:c.1378-18T>C:,ITGB4:ENST00000579662:splice_region&intron:LOW:exon11/38:c.1378-18T>C:,ITGB4:ENST00000339591:splice_region&intron:LOW:exon11/39:c.1378-18T>C:,ITGB4:ENST00000450894:splice_region&intron:LOW:exon11/38:c.1378-18T>C:,ITGB4:ENST00000449880:splice_region&intron:LOW:exon10/38:c.1378-18T>C:		rs373717293	0	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0000	0.0001							147557 [ITGB4 (confirmed) Epidermolysis bullosa,junctional,with pyloric atresia,226730|Epidermolysis bullosa,junctional,non-Herlitz type,226650|Epidermolysis bullosa of hands and feet,131800];				0	3					ITGB4 (inh=AR+AD pLI=0.00)
chr17	75489044	75489044	C	T	het	wt	wt	off-target	QUAL=299;DP=18,15,51;AF=0.72,0.00,0.00;MQM=60	SEPT9	splice_region&intron	SEPT9:ENST00000427177:splice_region&intron:LOW:exon9/11:c.1477-18C>T:,SEPT9:ENST00000591198:splice_region&intron:LOW:exon8/10:c.1420-18C>T:,SEPT9:ENST00000449803:splice_region&intron:LOW:exon9/11:c.985-18C>T:,SEPT9:ENST00000431235:splice_region&intron:LOW:exon9/11:c.985-18C>T:,SEPT9:ENST00000329047:splice_region&intron:LOW:exon8/10:c.1423-18C>T:,SEPT9:ENST00000590294:splice_region&intron:LOW:exon8/11:c.1423-18C>T:,SEPT9:ENST00000588690:splice_region&intron:LOW:exon8/11:c.985-18C>T:,SEPT9:ENST00000423034:splice_region&intron:LOW:exon8/10:c.1456-18C>T:,SEPT9:ENST00000427674:splice_region&intron:LOW:exon8/10:c.985-18C>T:,SEPT9:ENST00000585930:splice_region&intron:LOW:exon7/9:c.805-18C>T:,SEPT9:ENST00000541152:splice_region&intron:LOW:exon7/9:c.724-18C>T:,SEPT9:ENST00000591088:splice_region&intron:LOW:exon7/9:c.724-18C>T:,SEPT9:ENST00000592951:splice_region&intron:LOW:exon7/9:c.724-18C>T:,SEPT9:ENST00000427180:splice_region&intron:LOW:exon7/9:c.1141-18C>T:		rs774317900	0	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0000	0.0001							604061 [SEPT9 (confirmed) Leukemia,acute myeloid,therapy-related|Ovarian carcinoma|Amyotrophy,hereditary neuralgic,162100];				0	6					SEPT9 (inh=AD pLI=0.84)
chr17	78188805	78188805	G	A	het	wt	het	off-target	QUAL=1887;DP=82,89,84;AF=0.51,0.00,0.52;MQM=60	SGSH	intron	SGSH:ENST00000326317:intron:MODIFIER:exon3/7:c.355+27C>T:,SGSH:ENST00000534910:intron:MODIFIER:exon2/6:c.-254-241C>T:,SGSH:ENST00000570923:intron:MODIFIER:exon3/6:c.390+27C>T:		rs372556593	0.0002	0.0007	1,0,0	0.0001,0.0001,0.0000,0.0009,0.0011	0.0006							605270 [SGSH (confirmed) Mucopolysaccharidosis type IIIA (Sanfilippo A),252900];				0	7					SGSH (inh=AR pLI=0.00)
chrX	5808426	5808426	A	G	hom	wt	wt		QUAL=1566;DP=60,104,151;AF=0.95,0.00,0.00;MQM=60	NLGN4X	3'UTR	NLGN4X:ENST00000381093:3'UTR:MODIFIER:exon7/7:c.*2432T>C:,NLGN4X:ENST00000381095:3'UTR:MODIFIER:exon6/6:c.*2432T>C:,NLGN4X:ENST00000275857:3'UTR:MODIFIER:exon6/6:c.*2432T>C:			0	0	0,0,0	0,0,0,0,0	0							300427 [NLGN4X (provisional) Autism susceptibility,X-linked 2,300495|Asperger syndrome susceptibility,X-linked 2,300497|Mental retardation,X-linked,300495];				1	0					NLGN4X (inh=n/a pLI=0.90)
chrX	5810089	5810090	TA	-	wt	wt	het		QUAL=2821;DP=23,43,85;AF=0.04,0.49,0.96;MQM=60	NLGN4X	3'UTR	NLGN4X:ENST00000381093:3'UTR:MODIFIER:exon7/7:c.*768_*769delTA:,NLGN4X:ENST00000381095:3'UTR:MODIFIER:exon6/6:c.*768_*769delTA:,NLGN4X:ENST00000275857:3'UTR:MODIFIER:exon6/6:c.*768_*769delTA:	(TG)n:(TA)n	rs771211916	0	0	0,0,0	0,0,0,0,0	0.0002							300427 [NLGN4X (provisional) Autism susceptibility,X-linked 2,300495|Asperger syndrome susceptibility,X-linked 2,300497|Mental retardation,X-linked,300495];				0	20					NLGN4X (inh=n/a pLI=0.90)
chrX	10203077	10203077	G	T	wt	het	wt		QUAL=3054;DP=177,250,180;AF=0.01,0.48,0.00;MQM=60	CLCN4	3'UTR	CLCN4:ENST00000380833:3'UTR:MODIFIER:exon13/13:c.*1453G>T:	MLT1J	rs55847247	0.0013	0	0,0,0	0,0,0,0,0	0.0054							302910 [CLCN4 (provisional) Mental retardation,X-linked 49/15,300114];				1	2					CLCN4 (inh=XLR pLI=0.98)
chrX	10413758	10413758	A	G	hom	wt	wt		QUAL=3860;DP=125,252,213;AF=0.99,0.00,0.00;MQM=60	MID1	3'UTR	MID1:ENST00000317552:3'UTR:MODIFIER:exon10/10:c.*3650T>C:,MID1:ENST00000453318:3'UTR:MODIFIER:exon10/10:c.*3650T>C:,MID1:ENST00000380779:3'UTR:MODIFIER:exon10/10:c.*3650T>C:,MID1:ENST00000380780:3'UTR:MODIFIER:exon10/10:c.*3650T>C:,MID1:ENST00000380785:3'UTR:MODIFIER:exon11/11:c.*3650T>C:,MID1:ENST00000380787:3'UTR:MODIFIER:exon10/10:c.*3650T>C:		rs183965210	0.0032	0	0,0,0	0,0,0,0,0	0.0031							300552 [MID1 (confirmed) Opitz GBBB syndrome,type I,300000];				2	3					MID1 (inh=XLR pLI=0.39)
chrX	25022751	25022751	G	A	wt	het	wt		QUAL=3745;DP=177,278,20;AF=0.00,0.54,0.00;MQM=60	ARX	3'UTR	ARX:ENST00000379044:3'UTR:MODIFIER:exon5/5:c.*36C>T:			0	0	0,0,0	0,0,0,0,0	0.0001							300382 [ARX (confirmed) Epileptic encephalopathy,early infantile,1,308350|Lissencephaly,X-linked 2,300215|Mental retardation,X-linked 29 and others,300419|Proud syndrome,300004|Partington syndrome,309510|Hydranencephaly with abnormal genitalia,300215];				0	1					ARX (inh=XLR pLI=0.73)
chrX	39911629	39911629	C	T	wt	het	hom		QUAL=8586;DP=131,185,207;AF=0.00,0.49,0.99;MQM=60	BCOR	synonymous	BCOR:ENST00000378444:synonymous:LOW:exon15/15:c.5001G>A:p.Ser1667Ser,BCOR:ENST00000378463:synonymous:LOW:exon10/11:c.1530G>A:p.Ser510Ser,BCOR:ENST00000397354:synonymous:LOW:exon15/15:c.4899G>A:p.Ser1633Ser,BCOR:ENST00000378455:synonymous:LOW:exon14/14:c.4845G>A:p.Ser1615Ser,BCOR:ENST00000342274:synonymous:LOW:exon15/15:c.4899G>A:p.Ser1633Ser		rs375878497	0	0.0001	0,0,0	0.0000,0.0001,0.0000,0.0001,0.0002	0.0001	-1.5110		T			7.58	300485 [BCOR (confirmed) Microphthalmia,syndromic 2,300166];				1	1					BCOR (inh=XLD pLI=1.00)
chrX	41374941	41374941	-	A	hom	wt	wt		QUAL=3170;DP=133,232,112;AF=0.89,0.02,0.00;MQM=60	CASK	3'UTR	CASK:ENST00000421587:3'UTR:MODIFIER:exon25/25:c.*4731dupT:,CASK:ENST00000318588:3'UTR:MODIFIER:exon27/27:c.*4731dupT:,CASK:ENST00000361962:3'UTR:MODIFIER:exon26/26:c.*4731dupT:			0	0	0,0,0	0,0,0,0,0	0.0001							300172 [CASK (confirmed) Mental retardation and microcephaly with pontine and cerebellar hypoplasia,300749|FG syndrome 4,300422|Mental retardation,with or without nystagmus,300422];				1	0					CASK (inh=XLD pLI=1.00)
chrX	43605100	43605100	A	-	wt	het	hom		QUAL=4885;DP=50,61,137;AF=0.00,0.46,0.99;MQM=60	MAOA	3'UTR	MAOA:ENST00000338702:3'UTR:MODIFIER:exon15/15:c.*1341delA:			0	0	0,0,0	0,0,0,0,0	0							309850 [MAOA (confirmed) Brunner syndrome,300615|Antisocial behavior,300615];				1	1					MAOA (inh=XLR pLI=0.99)
chrX	48755490	48755490	G	T	wt	het	wt	off-target	QUAL=2760;DP=148,243,138;AF=0.00,0.47,0.00;MQM=60	PQBP1	intron	PQBP1:ENST00000376563:intron:MODIFIER:exon1/6:c.-19+114G>T:,PQBP1:ENST00000376566:intron:MODIFIER:exon1/5:c.-19+125G>T:,PQBP1:ENST00000376548:intron:MODIFIER:exon1/3:c.-19+125G>T:,PQBP1:ENST00000447146:intron:MODIFIER:exon1/6:c.-19+125G>T:,PQBP1:ENST00000247140:intron:MODIFIER:exon1/5:c.-19+193G>T:		rs41312118	0.0058	0	0,0,0	0,0,0,0,0	0.0074							300463 [PQBP1 (confirmed) Renpenning syndrome,309500];				0	1					PQBP1 (inh=XLR pLI=0.54)
chrX	49075326	49075326	G	A	wt	het	wt	off-target	QUAL=1076;DP=70,89,48;AF=0.00,0.55,0.00;MQM=60	CACNA1F	splice_region&intron	CACNA1F:ENST00000376265:splice_region&intron:LOW:exon22/47:c.2766+15C>T:,CACNA1F:ENST00000376251:splice_region&intron:LOW:exon22/47:c.2571+15C>T:,CACNA1F:ENST00000323022:splice_region&intron:LOW:exon22/47:c.2733+15C>T:		rs199570194	0.0008	0.0035	1,1,0	0.0005,0.0011,0.0000,0.0055,0.0000	0.0028							300110 [CACNA1F (confirmed) Night blindness,congenital stationary (incomplete),2A,X-linked,300071|Cone-rod dystrophy,X-linked,3,300476|Aland Island eye disease,300600];				7	12					CACNA1F (inh=XLR pLI=0.88)
chrX	53220927	53220927	T	C	hom	wt	wt		QUAL=2940;DP=99,168,82;AF=1.00,0.00,0.00;MQM=60	KDM5C	3'UTR	KDM5C:ENST00000452825:3'UTR:MODIFIER:exon24/24:c.*999A>G:		rs185115468	0.0005	0	0,0,0	0,0,0,0,0	0.0017							314690 [KDM5C (confirmed) Mental retardation,X-linked,syndromic,Claes-Jensen type,300534];				3	0					KDM5C (inh=XLR pLI=0.99)
chrX	53432375	53432375	T	C	wt	het	wt	off-target	QUAL=4152;DP=163,297,114;AF=0.00,0.56,0.00;MQM=60	SMC1A	intron	SMC1A:ENST00000322213:intron:MODIFIER:exon11/24:c.1911+50A>G:,SMC1A:ENST00000375340:intron:MODIFIER:exon8/9:c.1209+50A>G:		rs142064996	0.0024	0.0035	1,0,0	0.0012,0.0020,0.0000,0.0047,0.0006	0.0038							300040 [SMC1A (provisional) Cornelia de Lange syndrome 2,300590];				1	7					SMC1A (inh=XLR+XLD pLI=1.00)
chrX	53713640	53713640	G	CTGCTCCAGCCC	het	wt	wt		QUAL=7238;DP=76,117,58;AF=0.72,0.00,0.00;MQM=60	HUWE1	5'UTR	HUWE1:ENST00000262854:5'UTR:MODIFIER:exon1/84:c.-369delCinsGGGCTGGAGCAG:,HUWE1:ENST00000218328:5'UTR:MODIFIER:exon1/41:c.-369delCinsGGGCTGGAGCAG:			0	0	0,0,0	0,0,0,0,0	0							300697 [HUWE1 (provisional) Mental retardation,X-linked syndromic,Turner type,300706];				3	3					HUWE1 (inh=XLR+XLD pLI=1.00)
chrX	53963378	53963378	A	G	wt	het	wt		QUAL=510;DP=28,40,59;AF=0.00,0.53,0.00;MQM=60	PHF8	3'UTR	PHF8:ENST00000357988:3'UTR:MODIFIER:exon22/22:c.*2213T>C:,PHF8:ENST00000338154:3'UTR:MODIFIER:exon22/22:c.*2213T>C:,PHF8:ENST00000338946:3'UTR:MODIFIER:exon22/22:c.*1036T>C:		rs185305171	0.0021	0	0,0,0	0,0,0,0,0	0.0023							300560 [PHF8 (confirmed) Mental retardation syndrome,X-linked,Siderius type,300263];				0	1					PHF8 (inh=XLR pLI=1.00)
chrX	54069535	54069535	A	G	wt	het	wt		QUAL=501;DP=41,45,37;AF=0.00,0.53,0.00;MQM=60	PHF8	splice_region&intron,intron	PHF8:ENST00000322659:splice_region&intron:LOW:exon1/21:c.-93+9T>C:,PHF8:ENST00000357988:intron:MODIFIER:exon1/21:c.17-282T>C:,PHF8:ENST00000338154:intron:MODIFIER:exon1/21:c.-92-282T>C:,PHF8:ENST00000338946:intron:MODIFIER:exon1/21:c.-92-282T>C:		rs782493145	0	0	0,0,0	0,0,0,0,0	0.0016							300560 [PHF8 (confirmed) Mental retardation syndrome,X-linked,Siderius type,300263];				0	1					PHF8 (inh=XLR pLI=1.00)
chrX	62975023	62975023	T	G	hom	wt	wt		QUAL=3131;DP=109,256,119;AF=0.98,0.00,0.00;MQM=60	ARHGEF9	5'UTR,intron	ARHGEF9:ENST00000374870:5'UTR:MODIFIER:exon1/9:c.-946A>C:,ARHGEF9:ENST00000374878:intron:MODIFIER:exon1/9:c.3+29973A>C:,ARHGEF9:ENST00000437457:intron:MODIFIER:exon1/8:c.30+29973A>C:		rs782129950	0.0029	0	0,0,0	0,0,0,0,0	0.0048							300429 [ARHGEF9 (confirmed) Epileptic encephalopathy,early infantile,8,300607];				3	4					ARHGEF9 (inh=XLR pLI=0.98)
chrX	70390207	70390207	A	C	hom	wt	wt		QUAL=3216;DP=108,163,111;AF=0.99,0.00,0.02;MQM=60	NLGN3	3'UTR	NLGN3:ENST00000536169:3'UTR:MODIFIER:exon6/6:c.*260A>C:,NLGN3:ENST00000374051:3'UTR:MODIFIER:exon7/7:c.*260A>C:			0	0	0,0,0	0,0,0,0,0	0							300336 [NLGN3 (provisional) Autism susceptibility,X-linked 1,300425|Asperger syndrome susceptibility,X-linked 1,300494];				1	0					NLGN3 (inh=n/a pLI=0.86)
chrX	70465331	70465331	A	C	wt	het	wt		QUAL=3862;DP=179,299,141;AF=0.00,0.51,0.00;MQM=60	ZMYM3	synonymous	ZMYM3:ENST00000373988:synonymous:LOW:exon18/25:c.2871T>G:p.Leu957Leu,ZMYM3:ENST00000314425:synonymous:LOW:exon18/25:c.2865T>G:p.Leu955Leu,ZMYM3:ENST00000353904:synonymous:LOW:exon18/25:c.2865T>G:p.Leu955Leu,ZMYM3:ENST00000373998:synonymous:LOW:exon18/25:c.2829T>G:p.Leu943Leu,ZMYM3:ENST00000373984:synonymous:LOW:exon18/24:c.2871T>G:p.Leu957Leu		rs374745868	0	0.0002	0,0,0	0.0000,0.0000,0.0000,0.0004,0.0000	0.0002											0	1					ZMYM3 (inh=n/a pLI=1.00)
chrX	110406970	110406970	C	A	wt	het	hom	off-target	QUAL=2331;DP=57,53,58;AF=0.00,0.47,0.98;MQM=60	PAK3	splice_region&intron	PAK3:ENST00000360648:splice_region&intron:LOW:exon8/15:c.874+15C>A:,PAK3:ENST00000425146:splice_region&intron:LOW:exon7/14:c.766+15C>A:,PAK3:ENST00000446737:splice_region&intron:LOW:exon8/15:c.766+15C>A:,PAK3:ENST00000372010:splice_region&intron:LOW:exon11/18:c.811+15C>A:,PAK3:ENST00000519681:splice_region&intron:LOW:exon11/18:c.829+15C>A:,PAK3:ENST00000372007:splice_region&intron:LOW:exon10/17:c.766+15C>A:,PAK3:ENST00000518291:splice_region&intron:LOW:exon11/18:c.874+15C>A:,PAK3:ENST00000262836:splice_region&intron:LOW:exon7/14:c.811+15C>A:,PAK3:ENST00000417227:splice_region&intron:LOW:exon7/14:c.829+15C>A:		rs774044668	0	0.0001	0,0,0	0.0000,0.0000,0.0000,0.0001,0.0000	0.0001							300142 [PAK3 (confirmed) Mental retardation,X-linked 30/47,300558];				2	1					PAK3 (inh=XLR pLI=0.98)
chrX	110541090	110541090	C	G	wt	het	wt		QUAL=4122;DP=206,329,192;AF=0.00,0.49,0.00;MQM=60	DCX	3'UTR	DCX:ENST00000338081:3'UTR:MODIFIER:exon7/7:c.*3825G>C:,DCX:ENST00000371993:3'UTR:MODIFIER:exon7/7:c.*3825G>C:,DCX:ENST00000356915:3'UTR:MODIFIER:exon7/7:c.*3825G>C:		rs145764957	0.0034	0	0,0,0	0,0,0,0,0	0.0069							300121 [DCX (confirmed) Lissencephaly,X-linked,300067|Subcortical laminal heterotopia,X-linked,300067];				1	1					DCX (inh=XLR+XLD pLI=0.96)
chrX	119561929	119561929	A	G	wt	het	hom		QUAL=6634;DP=82,160,135;AF=0.00,0.53,1.00;MQM=60	LAMP2	3'UTR	LAMP2:ENST00000434600:3'UTR:MODIFIER:exon9/9:c.*410T>C:		rs41300908	0.0032	0	0,0,0	0,0,0,0,0	0.0095							309060 [LAMP2 (confirmed) Danon disease,300257];	367750 [uncertain significance DISEASE=hypertrophic_cardiomyopathy,danon_disease]; 			3	3					LAMP2 (inh=XLD pLI=0.93)
chrX	119563765	119563765	T	C	hom	wt	wt		QUAL=4352;DP=135,242,202;AF=1.00,0.00,0.00;MQM=60	LAMP2	intron	LAMP2:ENST00000434600:intron:MODIFIER:exon8/8:c.1094-1284A>G:,LAMP2:ENST00000538785:intron:MODIFIER:exon6/6:c.761-1284A>G:	(ACTTTT)n	rs773379092	0	0	0,0,0	0,0,0,0,0	0.001							309060 [LAMP2 (confirmed) Danon disease,300257];				1	0					LAMP2 (inh=XLD pLI=0.93)
chrX	135742258	135742258	C	T	wt	het	hom		QUAL=2116;DP=35,44,60;AF=0.00,0.45,1.00;MQM=58	CD40LG	3'UTR	CD40LG:ENST00000370629:3'UTR:MODIFIER:exon5/5:c.*684C>T:,CD40LG:ENST00000370628:3'UTR:MODIFIER:exon4/4:c.*684C>T:	(TC)n	rs779484195	0.0029	0	0,0,0	0,0,0,0,0	0.0068							300386 [CD40LG (confirmed) Immunodeficiency,X-linked,with hyper-IgM,308230];				1	2					CD40LG (inh=XLR pLI=0.84)
chrX	138644836	138644836	G	A	hom	wt	wt		QUAL=2686;DP=86,121,85;AF=1.00,0.00,0.00;MQM=60	F9	3'UTR	F9:ENST00000218099:3'UTR:MODIFIER:exon8/8:c.*606G>A:		rs191483077	0.0011	0	0,0,0	0,0,0,0,0	0.0077							300746 [F9 (confirmed) Hemophilia B,306900|Warfarin sensitivity,122700|Thrombophilia,X-linked,due to factor IX defect,300807|Deep venous thrombosis,protection against,300807];	368009 [likely benign DISEASE=hemophilia_b,_factor_ix_deficiency]; 			1	0					F9 (inh=XLR pLI=0.98)
chrX	153214721	153214721	T	G	het	het	wt		QUAL=104;DP=36,46,30;AF=0.33,0.33,0.00;MQM=60	HCFC1	3'UTR	HCFC1:ENST00000369984:3'UTR:MODIFIER:exon26/26:c.*77A>C:,HCFC1:ENST00000310441:3'UTR:MODIFIER:exon26/26:c.*77A>C:,HCFC1:ENST00000354233:3'UTR:MODIFIER:exon27/27:c.*77A>C:		rs782735671	0.0003	0	0,0,0	0,0,0,0,0	0.0059							300019 [HCFC1 (confirmed) Mental retardation,X-linked 3 (methylmalonic acidemia and homocysteinemia,cblX type ),309541];				0	2					HCFC1 (inh=XLR pLI=1.00)
chrX	153214725	153214725	A	G	het	het	wt		QUAL=104;DP=36,46,30;AF=0.33,0.33,0.00;MQM=60	HCFC1	3'UTR	HCFC1:ENST00000369984:3'UTR:MODIFIER:exon26/26:c.*73T>C:,HCFC1:ENST00000310441:3'UTR:MODIFIER:exon26/26:c.*73T>C:,HCFC1:ENST00000354233:3'UTR:MODIFIER:exon27/27:c.*73T>C:		rs781953961	0.0019	0	0,0,0	0,0,0,0,0	0.0039							300019 [HCFC1 (confirmed) Mental retardation,X-linked 3 (methylmalonic acidemia and homocysteinemia,cblX type ),309541];				0	3					HCFC1 (inh=XLR pLI=1.00)
chrX	153294998	153294998	C	G	hom	wt	wt		QUAL=4946;DP=169,265,118;AF=0.98,0.00,0.00;MQM=60	MECP2	3'UTR	MECP2:ENST00000303391:3'UTR:MODIFIER:exon4/4:c.*820G>C:		rs185146054	0.0032	0	0,0,0	0,0,0,0,0	0.0064							300005 [MECP2 (confirmed) Rett syndrome,312750|Mental retardation,X-linked,syndromic 13,300055|Rett syndrome,preserved speech variant,312750|Encephalopathy,neonatal severe,300673|Autism susceptibility,X-linked 3,300496|Mental retardation,X-linked syndromic,Lubs type,300260|Rett syndrome,atypical,312750];				5	4					MECP2 (inh=XLR+XLD pLI=0.65)
chrX	153640589	153640589	C	A	hom	wt	wt	off-target	QUAL=2517;DP=91,139,54;AF=0.98,0.00,0.00;MQM=60	TAZ	intron	TAZ:ENST00000299328:intron:MODIFIER:exon2/10:c.238+38C>A:,TAZ:ENST00000369790:intron:MODIFIER:exon2/8:c.238+38C>A:,TAZ:ENST00000350743:intron:MODIFIER:exon2/9:c.238+38C>A:,TAZ:ENST00000351413:intron:MODIFIER:exon2/9:c.238+38C>A:,TAZ:ENST00000369776:intron:MODIFIER:exon1/6:c.163+246C>A:,TAZ:ENST00000475699:intron:MODIFIER:exon2/9:c.238+38C>A:			0	0	0,0,0	0,0,0,0,0	0							300394 [TAZ (confirmed) Barth syndrome,302060];				1	0					TAZ (inh=XLR pLI=0.95)
chrX	154488153	154488153	C	T	wt	het	hom		QUAL=7463;DP=78,101,181;AF=0.00,0.52,1.00;MQM=60	RAB39B	3'UTR	RAB39B:ENST00000369454:3'UTR:MODIFIER:exon2/2:c.*1935G>A:		rs782447828	0.0005	0	0,0,0	0,0,0,0,0	0.0011							300774 [RAB39B (confirmed) Mental retardation,X-linked 72,300271|Waisman syndrome,311510];	368130 [likely benign DISEASE=non-syndromic_x-linked_intellectual_disability]; 			1	1					RAB39B (inh=XLR pLI=0.69)
chrMT	302	302	A	CCC	hom	hom	hom		QUAL=61187;DP=156,419,984;AF=0.17,0.42,0.36;MQM=57	CHR_START,MT,TF	intergenic_region	TF:CHR_START-ENSG00000210049:intergenic_region:MODIFIER::n.302delAinsCCC:			0	0	0,0,0	0,0,0,0,0	0											1	0					CHR_START (inh=n/a pLI=n/a), MCAT (inh=n/a pLI=0.00), TF (inh=AR pLI=0.03)
chrMT	309	309	-	T	wt	wt	wt		QUAL=61187;DP=156,419,984;AF=0.19,0.96,0.92;MQM=60	CHR_START,MT,TF	intergenic_region	TF:CHR_START-ENSG00000210049:intergenic_region:MODIFIER::n.309_310insT:			0	0	0,0,0	0,0,0,0,0	0											0	0					CHR_START (inh=n/a pLI=n/a), MCAT (inh=n/a pLI=0.00), TF (inh=AR pLI=0.03)
chrMT	309	309	-	CT	wt	wt	wt		QUAL=61187;DP=156,419,984;AF=0.17,0.93,0.93;MQM=60	CHR_START,MT,TF	intergenic_region	TF:CHR_START-ENSG00000210049:intergenic_region:MODIFIER::n.309_310insCT:			0	0	0,0,0	0,0,0,0,0	0											1	1					CHR_START (inh=n/a pLI=n/a), MCAT (inh=n/a pLI=0.00), TF (inh=AR pLI=0.03)
chrMT	430	430	T	C	hom	wt	wt		QUAL=54569;DP=1847,1268,2918;AF=0.99,0.00,0.00;MQM=59	CHR_START,MT,TF	intergenic_region	TF:CHR_START-ENSG00000210049:intergenic_region:MODIFIER::n.430T>C:			0	0	0,0,0	0,0,0,0,0	0											0	0					CHR_START (inh=n/a pLI=n/a), MCAT (inh=n/a pLI=0.00), TF (inh=AR pLI=0.03)
chrMT	14370	14370	A	G	wt	hom	hom		QUAL=191268;DP=2358,2181,3956;AF=0.00,0.99,0.99;MQM=59	MT-ND6	synonymous	MT-ND6:ENST00000361681:synonymous:LOW:exon1/1:c.304T>C:p.Leu102Leu			0	0	0,0,0	0,0,0,0,0	0											2	0					MT-ND6 (inh=MT pLI=n/a)
